On 8 October 2026 the second Zug Life Science Summit Meeting took place at GIBZ in Zug. 235 people attended this year for an afternoon of workshops and a meeting designed to drive great networking
The Workshops
An opening and then 8 insightful workshops:
1. The start up den - Biotech (Zug Pharma Group)
2. Investing in European biotech innovation (Covington)
3. Medical Affairs as a business accelerator: Innovation to patient value (Syneos Health)
4. Are you scaling AI - or just scaling cost (Marsh)
5. The start up den - HealthTech (Zug Pharma Group)
6. Pharma rewired: Navigating US-China shifts (Oliver Wyman)
7. Developing pharmaceuticals strategy - AI powered, human controlled (Branding Science Group)
8. Embedding AI in your company DNA (a-connect)
The Plenary
A plenary hosted by Marc Tiltman of the tug Pharma Group and opened by Thomas Fuchs of the Economic Development Team of the Canton of Zug, outlining the rich biotech environment in Zug
There followed 3 presentations on the theme of bringing innovation to reality
1. Dr Oliver Eitelwein (Oliver Wyman) outlining the future impact of technology and the drivers behind it. From AI to robotics to quantum, technology adoption will continue to accelerate
2. Tyler O'Neill (Evinova) outlining the impact of AI in improving clinical trials - the learning curve and the continuing improvements
3. Neil Archer (Madrigal Pharmaceuticals) outlining the challenges that Madrigal are facing in bringing an innovative treatment for MASH to the market in Europe. As a pioneer in a rapidly changing landscape there is no playbook - the company have to be steered by courage and a determination to bring their innovation to the patients who benefit